WO2004020580A8 - Single nucleotide polymorphisms diagnostic for schizophrenia - Google Patents

Single nucleotide polymorphisms diagnostic for schizophrenia

Info

Publication number: WO2004020580A8
Authority: WO; WIPO (PCT)
Prior art keywords: schizophrenia; single nucleotide; nucleotide polymorphisms; diagnostic; polymorphisms diagnostic
Prior art date: 2002-08-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

PCT/US2003/024799

Other languages

French (fr)

Other versions

WO2004020580A2 (en

WO2004020580A3 (en

Inventor

Paul S Kaytes

Chi-Hse Teng

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmacia and Upjohn Co

Original Assignee

Pharmacia and Upjohn Co

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-28

Filing date

2003-08-26

Publication date

2004-07-08

2002-08-28 Priority claimed from US10/230,007 external-priority patent/US20030170667A1/en

2003-08-26 Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co

2003-08-26 Priority to JP2004532878A priority Critical patent/JP2005537010A/en

2003-08-26 Priority to AU2003261460A priority patent/AU2003261460A1/en

2003-08-26 Priority to EP03791659A priority patent/EP1546398A4/en

2004-03-11 Publication of WO2004020580A2 publication Critical patent/WO2004020580A2/en

2004-07-08 Publication of WO2004020580A8 publication Critical patent/WO2004020580A8/en

2005-02-28 Anticipated expiration legal-status Critical

2005-04-14 Publication of WO2004020580A3 publication Critical patent/WO2004020580A3/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Pathology (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

PCT/US2003/024799 2002-08-28 2003-08-26 Single nucleotide polymorphisms diagnostic for schizophrenia Ceased WO2004020580A2 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
JP2004532878A JP2005537010A (en)	2002-08-28	2003-08-26	Single nucleotide polymorphism diagnosis of schizophrenia
AU2003261460A AU2003261460A1 (en)	2002-08-28	2003-08-26	Single nucleotide polymorphisms diagnostic for schizophrenia
EP03791659A EP1546398A4 (en)	2002-08-28	2003-08-26	Single nucleotide polymorphisms diagnostic for schizophrenia

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US40643202P	2002-08-28	2002-08-28
US60/406,432		2002-08-28
US10/230,007 US20030170667A1 (en)	2001-08-28	2002-08-28	Single nucleotide polymorphisms diagnostic for schizophrenia
US10/230,007		2002-08-28

Publications (3)

Publication Number	Publication Date
WO2004020580A2 WO2004020580A2 (en)	2004-03-11
WO2004020580A8 true WO2004020580A8 (en)	2004-07-08
WO2004020580A3 WO2004020580A3 (en)	2005-04-14

Family

ID=31980950

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/US2003/024799 Ceased WO2004020580A2 (en)	2002-08-28	2003-08-26	Single nucleotide polymorphisms diagnostic for schizophrenia

Country Status (4)

Country	Link
EP (1)	EP1546398A4 (en)
JP (1)	JP2005537010A (en)
AU (1)	AU2003261460A1 (en)
WO (1)	WO2004020580A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006023719A2 (en) *	2004-08-20	2006-03-02	Enh Research Institute	Identification of snp’s associated with schizophrenia, schizoaffective disorder and bipolar disorder
US7932042B1 (en)	2010-10-13	2011-04-26	Suregene, Llc	Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1237909A2 (en) *	1999-11-16	2002-09-11	PHARMACIA & UPJOHN COMPANY	Human g protein-coupled receptors
WO2002064789A1 (en) *	2001-02-14	2002-08-22	Pharmacia & Upjohn Company	Protein-coupled receptor
US20030170667A1 (en) *	2001-08-28	2003-09-11	Kaytes Paul S.	Single nucleotide polymorphisms diagnostic for schizophrenia

2003
- 2003-08-26 EP EP03791659A patent/EP1546398A4/en not_active Withdrawn
- 2003-08-26 AU AU2003261460A patent/AU2003261460A1/en not_active Abandoned
- 2003-08-26 WO PCT/US2003/024799 patent/WO2004020580A2/en not_active Ceased
- 2003-08-26 JP JP2004532878A patent/JP2005537010A/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO2004020580A2 (en)	2004-03-11
AU2003261460A8 (en)	2004-03-19
EP1546398A2 (en)	2005-06-29
JP2005537010A (en)	2005-12-08
WO2004020580A3 (en)	2005-04-14
EP1546398A4 (en)	2006-10-18
AU2003261460A1 (en)	2004-03-19

Publication	Publication Date	Title
AU2003259350A1 (en)	2004-03-11	Modified nucleotides for polynucleotide sequencing
AU2003237588A1 (en)	2004-02-02	Piston-actuated endoscopic steering system
AU2003212708A1 (en)	2003-09-16	Baculovirus expression system
AU2002353543A1 (en)	2003-12-02	Biosensor
AU2003266227A1 (en)	2003-12-22	Crossmember
EP1695251B8 (en)	2013-05-08	Clinical tool for structure localization
AU2003901671A0 (en)	2003-05-01	Comparative genomic hybridization
AU2002952938A0 (en)	2002-12-12	System for Conducting Clinical Trials
AU2003249846A1 (en)	2004-04-08	Bus
AU2002321851A1 (en)	2003-12-22	Novel linker for nucleotides
AU2002307172A1 (en)	2002-10-21	Haplotyping method for multiple distal nucleotide polymorphisms
AU2003250080A1 (en)	2004-02-09	Oligonucleotides for detecting micro-organisms
AU1922801A (en)	2001-05-30	Genomic polymorphism for predicting therapeutic response
AU2002324711A1 (en)	2003-03-18	Single nucleotide polymorphisms diagnostic for schizophrenia
AU2003299867A1 (en)	2004-07-29	Method for single nucleotide polymorphism detection
WO2004020580A3 (en)	2005-04-14	Single nucleotide polymorphisms diagnostic for schizophrenia
AU2001277997A1 (en)	2002-02-05	Diagnostic polymorphisms for the tgf-beta1 promoter
AU2003222965A1 (en)	2003-10-27	Schizophrenia associated genes
AU2003251424A1 (en)	2003-12-22	Electrochemical detection of single nucleotide polymorphisms (snps)
AU2003210259A1 (en)	2003-09-09	Method for detecting single nucleotide polymorphisms
AU3269401A (en)	2001-05-30	Simultaneous hybridization/priming for snp analysis
AU2003271889A1 (en)	2004-04-23	Hydrosilation catalyst
GB0229139D0 (en)	2003-01-15	Gene polymorphisms
AU2002366709A1 (en)	2003-07-09	Nucleotide polymorphisms associated with osteoporosis
AU2003238501A1 (en)	2003-12-31	Hybridization chamber

Legal Events

Date	Code	Title	Description
2004-03-11	AK	Designated states	Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW
2004-03-11	AL	Designated countries for regional patents	Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
2004-05-06	121	Ep: the epo has been informed by wipo that ep was designated in this application
2004-07-08	D17	Declaration under article 17(2)a
2004-09-30	DFPE	Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
2005-02-28	WWE	Wipo information: entry into national phase	Ref document number: 2004532878 Country of ref document: JP
2005-03-22	WWE	Wipo information: entry into national phase	Ref document number: 2003791659 Country of ref document: EP
2005-06-29	WWP	Wipo information: published in national office	Ref document number: 2003791659 Country of ref document: EP
2007-08-23	WWW	Wipo information: withdrawn in national office	Ref document number: 2003791659 Country of ref document: EP